CLINICAL_TRIALS
trial_result
· 2016-08-02
Clinical Trial Update: Phase II Clofarabine and Cytarabine for Newly Diagnosed Acute Myeloid Leukemia [Phase 2]
Summary
A Phase II study evaluating clofarabine plus cytarabine in newly diagnosed acute myeloid leukemia was terminated, with results posted in August 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Pittsburgh | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: TERMINATED | Results posted: 2016-08-02